Clinical trial Recruiting at 1 site Interventional Ages 25 to 80

Using patients' own blood to treat gum disease

Official title: Regenerative Treatment of Intrabony Defects With GTR and PRGF: A Randomised, Single-blind, Parallel-group Clinical Trial

Run by Queen Mary University of London · NCT04254861 · Data updated 2026-11-12

This study is testing whether using a treatment made from patients' own blood can help people with gum disease heal better than a traditional bone graft.

More Periodontal Diseases trials

Quick facts

Study typeInterventional
Ages25 Years to 80 Years
SexAll
Enrollment74 (estimated)
SponsorQueen Mary University of London
Academic / other
Locations1 site (London)
StatusRecruiting
StartedMarch 2, 2021
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJuly 6, 2026
Trial IDNCT04254861 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are systemically healthy adults aged 25 and older with clinical evidence of periodontitis and specific periodontal measurements.

Probably not a fit

Patients with serious medical conditions, recent antibiotic use, or those on chronic anticoagulant therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to treat patients with periodontitis through a minor gum surgery that compares two approaches: one using a product derived from the patient's own blood (PRGF) and the other using a traditional animal-derived bone graft. The study will involve 74 participants aged 25 and older, who will be randomly assigned to receive one of the two treatments. Over a 12-month period, the health of the gums will be assessed through various measurements and non-invasive technologies. The trial follows rigorous standards to ensure reliable results.

Why it matters

Potential benefit: If successful, this approach could lead to improved healing and regeneration of gum and bone tissue in patients with periodontal disease.

How similar studies have gone: Previous studies have shown positive outcomes with similar approaches in treating periodontal defects, suggesting potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Systemically healthy males and females ≥25 years old
* Willingness to read and sign a copy of the Informed Consent Form after reading the Patient Information Sheet, and after the nature of the study has been fully explained
* Clinical evidence of periodontitis, with one interdental area of PPD ≥6mm, BOP, and attachment loss ≥6mm, with associated intrabony defect ≥3mm in any area of their mouth (excluding third molars and distal of second molars)
* Full mouth bleeding and plaque scores (FMBS and FMPS) \<25%recorded within the previous 6 weeks
* Non-surgical treatment completed within 6 months prior to assessment for eligibility

Exclusion Criteria:

* Medical history that includes diabetes type 1 or hepatic or renal disease, or other serious medical conditions or transmittable diseases (e.g. cardiovascular disease or AIDS).
* Antibiotic or anti-inflammatory therapy during the month preceding the baseline exam.
* In chronic treatment (\>2 weeks) with anticoagulants, corticosteroids or other medications that can severely impact on bone formation
* History of alcohol or drug abuse.
* Smoking ≥10 cigarettes a day
* Self-reported pregnancy or lactation (this criterion is due to oral tissue changes related to pregnancy and nursing, which can affect interpretation of study results).
* Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or investigational product administration or may interfere with the interpretation of trial results and, in the judgement of the investigator, would make the subject inappropriate for entry into this trial.
* Periodontal surgery in the same area selected for the study within the past 12 months.

Where it's running

  • Barts and The London Dental Hospital
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.